MedTrace Logo

Khushi Baby (KB): Novel Mobile Health Solution for Vaccination Record Keeping in India

NCT02518178 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2015-08-07

No results posted yet for this study

Summary

This is a three arm cluster randomized controlled trial where the unit of randomization is the immunization camp. Immunization camps are the sole provider of vaccinations in our study area and have catchment areas of several villages. The 96 immunization camps will be randomized evenly to one of three arms:

1. control arm; where near field communication (NFC) stickers will be placed on existing immunization booklets. These stickers can be scanned using a mobile phone with an installed application whereby information can be entered onto the phone and then scanned onto the sticker
2. pendant only; where the same NFC technology will be placed into a pendant that is worn by the infant, and
3. pendant as described above with voice reminders sent 15 days, 1 day prior, and the day of the scheduled immunization camp dates.

Conditions

  • DTP Vaccine Series Completion

Interventions

DEVICE

NFC Necklace

DEVICE

Voice Reminder

Dialect-specific reminders will be issued to the mother's cell phone, informing about the upcoming immunization camp and the importance of vaccination

DEVICE

NFC Sticker

NFC Sticker on existing immunization card (MAMTA card) serves as a comparator to the pendant and pendant+voice call arms.

Sponsors & Collaborators

  • Indian Institute of Health Management Research (IIHMR)

    collaborator UNKNOWN

  • Seva Mandir, India

    collaborator UNKNOWN

  • Johns Hopkins Bloomberg School of Public Health

    collaborator OTHER

  • Khushi Baby Inc.

    lead OTHER

Principal Investigators

  • Mohammad Shahnawaz, PhD cand · Indian Institute of Health Management Research (IIHMR)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
42 Days
Max Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-04-30
Completion
2016-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02518178 on ClinicalTrials.gov